Report cover image

Hand, Foot and Mouth Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Publisher Global Markets Direct
Published May 31, 2022
Length 51 Pages
SKU # GMD17226464

Description

Hand, Foot and Mouth Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hand, Foot and Mouth Disease - Drugs In Development, 2022, provides an overview of the Hand, Foot and Mouth Disease (Infectious Disease) pipeline landscape.

Hand, foot and mouth disease is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease (HFMD) is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite and ulcers in the throat (including tonsils), mouth, and tongue. Treatment includes antibiotics and pain relievers.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Hand, Foot and Mouth Disease - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed and Preclinical stages are 1, 2, 2 and 8 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 4 and 5 molecules, respectively.

Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Hand, Foot and Mouth Disease (Infectious Disease).
  • The pipeline guide reviews pipeline therapeutics for Hand, Foot and Mouth Disease (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Hand, Foot and Mouth Disease (Infectious Disease) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Hand, Foot and Mouth Disease (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Hand, Foot and Mouth Disease (Infectious Disease)
Reasons to Buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Hand, Foot and Mouth Disease (Infectious Disease).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Hand, Foot and Mouth Disease (Infectious Disease) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

51 Pages
Introduction
Global Markets Direct Report Coverage
Hand, Foot and Mouth Disease – Overview
Hand, Foot and Mouth Disease – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hand, Foot and Mouth Disease – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hand, Foot and Mouth Disease – Companies Involved in Therapeutics Development
Adimmune Corp
AIM Vaccine Co Ltd
Beijing Kangleweishi Biotechnology Co Ltd
Beijing Minhai Biotechnology Co Ltd
BioKangtai Co
Changchun Bcht Biotechnology Co Ltd
Chongqing Zhifei Biological Products Co Ltd
Emergex Vaccines Holding Ltd
HK inno.N Corp
Quratis Inc
Sentinext Therapeutics Sdn Bhd
Shanghai Zerun Biotechnology Co Ltd
Hand, Foot and Mouth Disease – Drug Profiles
(coxsackievirus [serotype A16] + enterovirus [serotype 71]) vaccine – Drug Profile
B-1108 – Drug Profile
CJ-40010 – Drug Profile
D-5 – Drug Profile
DC-07090 – Drug Profile
DMA-135 – Drug Profile
E-71 – Drug Profile
enterovirus [serotype 71] (virus like particle) vaccine – Drug Profile
Enterovirus [serotype EV-71/C4] vaccine – Drug Profile
Enterovirus [serotype EV-A71] (virus like particle, bivalent) vaccine – Drug Profile
Enterovirus [serotype EV-A71] vaccine – Drug Profile
foot and mouth disease vaccine – Drug Profile
hand, foot and mouth disease (bivalent) vaccine – Drug Profile
hand, foot and mouth disease (bivalent, virus like particle) vaccine – Drug Profile
hand, foot and mouth disease (virus like particle) vaccine – Drug Profile
hand, foot and mouth disease vaccine – Drug Profile
Monoclonal Antibody for Hand, Foot and Mouth Disease – Drug Profile
Small Molecules for Hand, Foot and Mouth Disease – Drug Profile
Small Molecules for Hand, Foot and Mouth Disease (HFMD) – Drug Profile
Small Molecules to Inhibit MAP2K1 for Hand, Foot and Mouth Disease – Drug Profile
STX-100 – Drug Profile
Hand, Foot and Mouth Disease – Dormant Projects
Hand, Foot and Mouth Disease – Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Table 1: Number of Products under Development for Hand, Foot and Mouth Disease, 2022
Table 2: Number of Products under Development by Companies, 2022
Table 3: Number of Products under Development by Universities/Institutes, 2022
Table 4: Products under Development by Companies, 2022
Table 5: Products under Development by Universities/Institutes, 2022
Table 6: Number of Products by Stage and Target, 2022
Table 7: Number of Products by Stage and Mechanism of Action, 2022
Table 8: Number of Products by Stage and Route of Administration, 2022
Table 9: Number of Products by Stage and Molecule Type, 2022
Table 10: Hand, Foot and Mouth Disease – Pipeline by Adimmune Corp, 2022
Table 11: Hand, Foot and Mouth Disease – Pipeline by AIM Vaccine Co Ltd, 2022
Table 12: Hand, Foot and Mouth Disease – Pipeline by Beijing Kangleweishi Biotechnology Co Ltd, 2022
Table 13: Hand, Foot and Mouth Disease – Pipeline by Beijing Minhai Biotechnology Co Ltd, 2022
Table 14: Hand, Foot and Mouth Disease – Pipeline by BioKangtai Co, 2022
Table 15: Hand, Foot and Mouth Disease – Pipeline by Changchun Bcht Biotechnology Co Ltd, 2022
Table 16: Hand, Foot and Mouth Disease – Pipeline by Chongqing Zhifei Biological Products Co Ltd, 2022
Table 17: Hand, Foot and Mouth Disease – Pipeline by Emergex Vaccines Holding Ltd, 2022
Table 18: Hand, Foot and Mouth Disease – Pipeline by HK inno.N Corp, 2022
Table 19: Hand, Foot and Mouth Disease – Pipeline by Quratis Inc, 2022
Table 20: Hand, Foot and Mouth Disease – Pipeline by Sentinext Therapeutics Sdn Bhd, 2022
Table 21: Hand, Foot and Mouth Disease – Pipeline by Shanghai Zerun Biotechnology Co Ltd, 2022
Table 22: Hand, Foot and Mouth Disease – Dormant Projects, 2022
Table 23: Hand, Foot and Mouth Disease – Discontinued Products, 2022
List of Figures
Figure 1: Number of Products under Development for Hand, Foot and Mouth Disease, 2022
Figure 2: Number of Products under Development by Companies, 2022
Figure 3: Number of Products under Development by Universities/Institutes, 2022
Figure 4: Number of Products by Targets, 2022
Figure 5: Number of Products by Stage and Targets, 2022
Figure 6: Number of Products by Mechanism of Actions, 2022
Figure 7: Number of Products by Stage and Mechanism of Actions, 2022
Figure 8: Number of Products by Routes of Administration, 2022
Figure 9: Number of Products by Stage and Routes of Administration, 2022
Figure 10: Number of Products by Molecule Types, 2022
Figure 11: Number of Products by Stage and Molecule Types, 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us